Cargando…

CSF 14-3-3β is associated with progressive cognitive decline in Alzheimer’s disease

Alzheimer’s disease is a neurodegenerative disorder characterized pathologically by amyloid-beta plaques, tau tangles and neuronal loss. In clinical practice, the 14-3-3 isoform beta (β) is a biomarker that aids in the diagnosis of sporadic Creutzfeldt–Jakob disease. Recently, a proteomics study fou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiang, Qiang, Skudder-Hill, Loren, Toyota, Tomoko, Huang, Zhe, Wei, Wenshi, Adachi, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684297/ https://www.ncbi.nlm.nih.gov/pubmed/38035365 http://dx.doi.org/10.1093/braincomms/fcad312

Ejemplares similares

CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer’s disease
por: Qiang, Qiang, et al.
Publicado: (2022)

BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2021)

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease
por: Kim, Jun Pyo, et al.
Publicado: (2022)

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial
por: Abdullah, Laila, et al.
Publicado: (2020)

Association of CSF Aβ(38) Levels With Risk of Alzheimer Disease–Related Decline
por: Cullen, Nicholas, et al.
Publicado: (2022)

CSF tau protein and FDG PET in patients with aging-associated cognitive decline and Alzheimer’s disease
por: Hunt, Aoife, et al.
Publicado: (2006)

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
por: Brier, Matthew R., et al.
Publicado: (2016)

Comparison of plasma and CSF biomarkers in predicting cognitive decline
por: Aschenbrenner, Andrew J., et al.
Publicado: (2022)

CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline
por: Suárez‐Calvet, Marc, et al.
Publicado: (2018)

Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non‐demented adults
por: Ennis, Gilda E., et al.
Publicado: (2021)

Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer’s disease
por: Liu, Yu-Hui, et al.
Publicado: (2021)

14-3-3 and enolase abundances in the CSF of Prion diseased rats
por: Gushue, Danielle, et al.
Publicado: (2018)

Association of CSF, Plasma, and Imaging Markers of Neurodegeneration With Clinical Progression in People With Subjective Cognitive Decline
por: Ebenau, Jarith L., et al.
Publicado: (2022)

Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer’s Disease
por: Geijselaers, Stefan L.C., et al.
Publicado: (2017)

CSF tau is associated with impaired cortical plasticity, cognitive decline and astrocyte survival only in APOE4-positive Alzheimer’s disease
por: Koch, Giacomo, et al.
Publicado: (2017)

Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline
por: Nair, Ajay Kumar, et al.
Publicado: (2022)

Periodontitis and Cognitive Decline in Alzheimer’s Disease
por: Ide, Mark, et al.
Publicado: (2016)

Reversal of cognitive decline in Alzheimer's disease
por: Bredesen, Dale E., et al.
Publicado: (2016)

Cognitive Decline: Not Always Alzheimer’s Disease
por: Villalba, Noel Lorenzo, et al.
Publicado: (2018)

Phosphorylated Glycogen Synthase Kinase-3β (GSK-3β) Improves Cognition in Rats with Diabetes-Associated Cognitive Decline
por: Ke, Boxi, et al.
Publicado: (2019)

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression
por: Liguori, Claudio, et al.
Publicado: (2018)

The Relationship between Abdominal Fat Phenotypes and Insulin Resistance in Non-Obese Individuals after Acute Pancreatitis
por: Ko, Juyeon, et al.
Publicado: (2020)

Pancreatic enzymes and abdominal adipose tissue distribution in new-onset prediabetes/diabetes after acute pancreatitis
por: Ko, Juyeon, et al.
Publicado: (2021)

Retracted: Phosphorylated Glycogen Synthase Kinase-3β (GSK-3β) Improves Cognition in Rats with Diabetes-Associated Cognitive Decline
por: Ke, Boxi, et al.
Publicado: (2019)

Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
por: Lerche, Stefanie, et al.
Publicado: (2023)

Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline
por: Nair, Ajay Kumar, et al.
Publicado: (2023)

Cognitive Declines Precede and Predict Functional Declines in Aging and Alzheimer’s Disease
por: Zahodne, Laura B., et al.
Publicado: (2013)

β-amyloid and tau drive early Alzheimer’s disease decline while glucose hypometabolism drives late decline
por: Hammond, Tyler C., et al.
Publicado: (2020)

Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
por: Boza-Serrano, Antonio, et al.
Publicado: (2022)

Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
por: Dansson, Hákon Valur, et al.
Publicado: (2021)

Progress in blood biomarkers of subjective cognitive decline in preclinical Alzheimer's disease
por: Yu, Xianfeng, et al.
Publicado: (2023)

Preterm Birth is Associated With Increased Blood Pressure in Young Adult Women
por: Skudder‐Hill, Loren, et al.
Publicado: (2019)

CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease
por: Hu, William T., et al.
Publicado: (2016)

Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
por: Galasko, Douglas, et al.
Publicado: (2019)

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
por: Papaliagkas, Vasileios, et al.
Publicado: (2023)

Retinal nerve fiber layer thickness predicts CSF amyloid/tau before cognitive decline
por: Asanad, Samuel, et al.
Publicado: (2020)

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease
por: Lim, Y Y, et al.
Publicado: (2015)

CSF level of β-amyloid peptide predicts mortality in Alzheimer’s disease
por: Boumenir, Adla, et al.
Publicado: (2019)

Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ(42) decline in non-demented elders
por: Dou, Kai-Xin, et al.
Publicado: (2019)

Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors
por: Musicco, Massimo, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_74rvkj41ik1mmhgudecht021gr